Qyuns Therapeutics Subscribes to Two Wealth Management Products from Shanghai Pudong Development Bank; Shares Fall 1%
MT Newswires Live
Jul 07
Qyuns Therapeutics (HKG:2509) said it would funnel 120 million yuan in idle funds to two wealth management products offered by Shanghai Pudong Development Bank (SHA:600000), according to a Friday Hong Kong bourse filing.
Shares fell over 1% in morning trade Monday.
The first product is worth 60 million yuan with a guaranteed yield of 0.70% and a floating mid-range yield of 0% or 0.95% or a 1.15% high-range floating yield.
The second product is worth 60 million yuan with a guaranteed yield of 0.70% and a floating mid-range yield of 0% or 1.20% or a high-range yield of 1.40%, the filing said.
Both products will mature on Oct. 9.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.